MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis

MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis

Wen-Zhao Luo,1,2 Xian Li,2 Xiu-Xia Wu,2 Yi-Wan Shang,1,3 Dan-Hua Meng,1,3 Yu-Long Chen,1,3 Qin-Sheng Zhang2 1School of Basic Medicine (Zhongjing School), Henan University of Chinese Medicine, Zhengzhou, Henan Province, 45000, People’s Republic of China; 2Department of Hepatobiliary and Spleen Stomac...

Full description

Bibliographic Details
Main Authors:	Luo WZ, Li X, Wu XX, Shang YW, Meng DH, Chen YL, Zhang QS
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-05-01
Series:	International Journal of General Medicine
Subjects:	stomach adenocarcinoma maged4b prognosis biomarkers
Online Access:	https://www.dovepress.com/maged4b-is-a-poor-prognostic-marker-of-stomach-adenocarcinoma-and-a-po-peer-reviewed-fulltext-article-IJGM

Similar Items

Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma
by: Lili Guo, et al.
Published: (2022-08-01)

Identification of a metabolic-related gene signature predicting the overall survival for patients with stomach adenocarcinoma
by: Yuan Nie, et al.
Published: (2021-02-01)

Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
by: Zhou Daxiang, et al.
Published: (2023-07-01)

Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
by: Lamei Li, et al.
Published: (2023-05-01)

Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma
by: Jing Yang, et al.
Published: (2023-04-01)

Increased <i>SEC23A</i> Expression Correlates with Poor Prognosis and Immune Infiltration in Stomach Adenocarcinoma
by: Su Zhaoran, et al.
Published: (2023-03-01)

Hepatic metastases from hepatoid adenocarcinoma of stomach mimicking hepatocellular carcinoma
by: Jae Myeong Jo, et al.
Published: (2012-12-01)

Hepatoid adenocarcinoma of the stomach: CT findings
by: Qian Yang, et al.
Published: (2023-02-01)

Comprehensive analysis of peroxisome proliferator-activated receptors to predict the drug resistance, immune microenvironment, and prognosis in stomach adenocarcinomas
by: Qing Jia, et al.
Published: (2024-03-01)

Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis
by: Kehui Zhang, et al.
Published: (2022-05-01)

Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling
by: Chunhua Liu, et al.
Published: (2022-08-01)

Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS)
by: Xuesong Yang, et al.
Published: (2023-01-01)

Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma
by: Qingjun Wang, et al.
Published: (2022-06-01)

The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study
by: Tuba Baydas, et al.
Published: (2023-04-01)

Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases
by: Xuesong Yang, et al.
Published: (2024-01-01)

Establishment of the molecular subtypes and a risk model for stomach adenocarcinoma based on genes related to reactive oxygen species
by: Guangyao Li, et al.
Published: (2024-03-01)

A rare hepatoid adenocarcinoma in the stomach of a female patient
by: Xinwei Ya, et al.
Published: (2024-02-01)

Comprehensive analysis of the oncogenic roles of vascular endothelial growth factors and their receptors in stomach adenocarcinoma
by: Jianxin Li, et al.
Published: (2023-07-01)

Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma
by: Jingjing Pan, et al.
Published: (2022-12-01)

Long-term survival of a patient with advanced hepatoid type adenocarcinoma of stomach and liver metastasis
by: Chao-Chien Hung, et al.
Published: (2019-01-01)

Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma
by: Dun Pan, et al.
Published: (2023-11-01)

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
by: Weiqiang You, et al.
Published: (2022-07-01)

Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma
by: Baokang Wu, et al.
Published: (2023-01-01)

A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma
by: Zhaoxiang Song, et al.
Published: (2023-12-01)

Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance
by: Lina Lu, et al.
Published: (2023-12-01)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
by: Tianyou Liao, et al.
Published: (2022-10-01)

Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages
by: Ji Young Kang, et al.
Published: (2020-05-01)

Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction
by: Yong Zhang, et al.
Published: (2023-01-01)

Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations
by: Rongjie Zhao, et al.
Published: (2022-08-01)

Early hepatoid adenocarcinoma of the stomach with signet ring cell carcinoma: A case report and clinicopathological features
by: Xinglong Wu, et al.
Published: (2023-01-01)

DNA cytosine deamination is associated with recurrent Somatic Copy Number Alterations in stomach adenocarcinoma
by: Yilin Shi, et al.
Published: (2023-10-01)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
by: Jing Yang, et al.
Published: (2022-12-01)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
by: Zhijin Zhang, et al.
Published: (2023-06-01)

Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta gene as a tumour suppressor in stomach adenocarcinoma
by: Yun Li, et al.
Published: (2022-11-01)

Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma
by: Renlong Zhou, et al.
Published: (2022-08-01)

Hepatoid Adenocarcinoma of the Stomach: A Rare Tumour in an Unusual Subserosal Location
by: KASIMSETTY RAMAKANTHA CHATURA, et al.
Published: (2023-12-01)

THE INFLUENCE OF HUMAN LEUKEMIA DIFFERENTIATION FACTOR ON ABILITY OF BLOOD CELLS TO PRODUCE IL-1β, IL-1ra AND IL-8 IN CHRONIC ATROPHIC GASTRITIS, ADENOMAS AND ADENOCARCINOMAS OF THE STOMACH
by: A. V. Sosnina, et al.
Published: (2015-04-01)

ITGA11, a Prognostic Factor Associated with Immunity in Gastric Adenocarcinoma
by: Yang X, et al.
Published: (2024-02-01)

Images du Mage, images pour le Mage
by: Daniel Grégorio

Protein expression of TGF-β, SMAD2 and RUNX3 in normal stomach, chronic gastritis and gastric adenocarcinoma
by: Ismail, Ahmad Zharif
Published: (2016)